CompletedNot applicableNCT02748044
Validation of the Utility of Rare Disease Intelligence Platform
Studying Rare disorder with lens opacification
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sun Yat-sen University
- Principal Investigator
- Haotian Lin, M.D., Ph.DZhongshan Ophthalmic Center, Sun Yat-sen University
- Intervention
- CC-Cruiser(device)
- Enrollment
- 53 enrolled
- Eligibility
- 80 years · All sexes
- Timeline
- 2012 – 2016
Study locations (4)
- Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China
- Department of Ophthalmology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China
- Department of Ophthalmology, First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong, China
- Department of Ophthalmology, Qingyuan People's Hospital, Qingyuan, Guangdong, China
Collaborators
Ministry of Health, China · Xidian University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02748044 on ClinicalTrials.gov